✦ LIBER ✦

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

✍ Scribed by Francesco Matrisciano; Stefania Bonaccorso; Angelo Ricciardi; Sergio Scaccianoce; Isabella Panaccione; Lily Wang; Amedo Ruberto; Roberto Tatarelli; Ferdinando Nicoletti; Paolo Girardi; Richard C. Shelton

Book ID: 113750403
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 138 KB
Volume: 43
Category: Article
ISSN: 0022-3956
DOI: 10.1016/j.jpsychires.2008.03.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH19 COMPARATIVE ANALYSIS OF THE EFFICA

PMH19 COMPARATIVE ANALYSIS OF THE EFFICACY AND SAFETY OF ESCITALOPRAM WITH SERTRALINE AND VENLAFAXINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

✍ J Walczak; S Matysiak; M Rowinska 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Changes in serum runt-related transcript

Changes in serum runt-related transcription factor 2 levels after a 6-month treatment with recombinant human parathyroid hormone in patients with osteoporosis

✍ W. Zhu,M. L. Yang,G. Y. Yang,G. Boden… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 155 KB

Efficacy and safety of duloxetine for tr

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

✍ I. Jon Russell; Philip J. Mease; Timothy R. Smith; Daniel K. Kajdasz; Madelaine 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 608 KB